Display Settings:

Format

Send to:

Choose Destination
    Ann Surg. 2006 Jan;243(1):115-20.

    The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly.

    Source

    Department of Surgery, University of Texas Medical Branch, and Shriners Hospitals for Children, Galveston, TX 77550, USA. rbarrow@utmb.edu

    Abstract

    OBJECTIVE:

    The objective of this study was to test the hypothesis that hepatomegaly in burned children can be attenuated or reversed by blocking lipolysis and reducing free fatty acids delivered to the liver.

    SUMMARY BACKGROUND DATA:

    Accelerated lipolysis in severely burned children has been shown to play an important role in the accumulation of hepatic TGs. Severely burned children who survive 10 days or more after injury commonly have enlarged livers often twice or more normal size for their sex, age, and weight.

    METHODS:

    Ninety-eight children, 2 to 18 years of age, with burns covering more than 40% of their body surface and who received either propranolol (beta-adrenergic blockade) or placebo were studied. Liver weights were measured by ultrasonic scanning. Body composition changes were identified by dual-image x-ray absorptiometry and validated by whole-body potassium-40 scintillation counting. Discarded abdominal cutaneous adipose tissue was collected before and after propranolol or placebo for microarray analysis.

    RESULTS:

    In 80% of severely burned children studied not receiving propranolol, liver sizes increased by 100% or more while 86% of burned children receiving propranolol showed a decrease or no change in liver size over the same period of time after injury. Gene expression patterns of adipose tissue after propranolol treatment showed that all of the identified genes related to lipid metabolism were down-regulated.

    CONCLUSIONS:

    Data reported here support the hypothesis that beta-adrenergic blockade can reduce delivery of fatty acids to the liver and hepatic congestion commonly found in severely burned children by inhibiting lipolysis and reducing hepatic blood flow.

    PMID:
    16371745
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1449976
    Free PMC Article

    Images from this publication.See all images (2) Free text

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk